Kamada (NASDAQ: KMDA)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-10 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.020 | -0.040 | -0.0600 | ||||
REV | 25.630M | 28.093M | 2.463M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Kamada (NASDAQ: KMDA) through any online brokerage.
There are no as such competitors for Kamada.
The latest price target for Kamada (NASDAQ: KMDA) was reported by Chardan Capital on Friday, February 2, 2018. The analyst firm set a price target for 7.00 expecting KMDA to rise to within 12 months (a possible 51.84% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Kamada (NASDAQ: KMDA) is $4.61 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for Kamada.
Kamada’s Q2 earnings are confirmed for Wednesday, August 10, 2022.
There is no upcoming split for Kamada.
Kamada is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.